摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl 2-[(hexahydro-2,5-methanopentalen-3a(1H)-ylcarbonyl)amino]-4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxylate | 1101855-16-6

中文名称
——
中文别名
——
英文名称
ethyl 2-[(hexahydro-2,5-methanopentalen-3a(1H)-ylcarbonyl)amino]-4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxylate
英文别名
2-[(hexahydro-2,5-methano-pentalene-3a-carbonyl)-amino]-4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxylic acid ethyl ester;ethyl 2-(tricyclo[3.3.1.03,7]nonane-3-carbonylamino)-5,7-dihydro-4H-thieno[2,3-c]pyran-3-carboxylate
ethyl 2-[(hexahydro-2,5-methanopentalen-3a(1H)-ylcarbonyl)amino]-4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxylate化学式
CAS
1101855-16-6
化学式
C20H25NO4S
mdl
——
分子量
375.489
InChiKey
PRFBSUSJVNWSMH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.8
  • 重原子数:
    26
  • 可旋转键数:
    5
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.7
  • 拓扑面积:
    92.9
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Synthesis and evaluation of 2-amido-3-carboxamide thiophene CB2 receptor agonists for pain management
    摘要:
    SAR studies on a series of thiophene amide derivatives provided CB2 receptor agonists. The activity of the compounds was characterized by radioligand binding determination, multiple functional assays, ADME, and pharmacokinetic studies. A representative compound with selectivity for CB2 over CB1 effectively produced analgesia in behavioral models of neuropathic, inflammatory, and postsurgical pain. Control experiments using a CB2 antagonist demonstrated the efficacy in the pain models resulted from CB2 agonism. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2012.01.121
  • 作为产物:
    参考文献:
    名称:
    Synthesis and evaluation of 2-amido-3-carboxamide thiophene CB2 receptor agonists for pain management
    摘要:
    SAR studies on a series of thiophene amide derivatives provided CB2 receptor agonists. The activity of the compounds was characterized by radioligand binding determination, multiple functional assays, ADME, and pharmacokinetic studies. A representative compound with selectivity for CB2 over CB1 effectively produced analgesia in behavioral models of neuropathic, inflammatory, and postsurgical pain. Control experiments using a CB2 antagonist demonstrated the efficacy in the pain models resulted from CB2 agonism. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2012.01.121
点击查看最新优质反应信息

文献信息

  • NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS
    申请人:Carroll William A.
    公开号:US20090018114A1
    公开(公告)日:2009-01-15
    The present application relates to cannabinoid receptor ligands containing compounds of formula (I) wherein A, R 1 , R 2 , and R 3 are as defined in the specification. The present application also relates to compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.
    本申请涉及含有式(I)化合物的大麻素受体配体,其中A、R1、R2和R3如规范中所定义。本申请还涉及包含这种化合物的组合物,以及使用这种化合物和组合物治疗疾病和疾病的方法。
  • US8338623B2
    申请人:——
    公开号:US8338623B2
    公开(公告)日:2012-12-25
查看更多

同类化合物

化合物SEP-363856HYDROCHLORIDE 6,7-二氢-4H-噻吩并[3,2-c]吡喃-4-甲胺 6,7-二氢-4H-噻吩并[3,2-c]吡喃-2-羧酸乙酯 6,7-二氢-4H-噻吩并[3,2-c]吡喃-2-羧酸 5,7-二氢-4H-噻吩并[2,3-c]吡喃-3-羧酸 5,7-二氢-4H-噻吩并[2,3-C]吡喃-3-羧酸乙酯 4-(2-羟基乙基)-4-甲基-6,7-二氢-4h-噻吩并[3,2-c]吡喃 4,5-二氢螺[哌啶-4,7-噻吩并[2,3-c]吡喃] 4',5'-二氢-螺[哌啶-4,7'-[7H]噻吩并[2,3-c]吡喃]-1-羧酸叔丁酯 2-氯-4,5-二氢螺[哌啶-4,7-噻吩并[2,3-c]吡喃] 2-氨基-5,5-二甲基-4,7-二氢-5H-噻吩并[2,3-C]吡喃-3-羧酸叔丁酯 2-氨基-4,7-二氢-5H-噻吩并[2,3-c]吡喃-3-羧酸乙酯 2-氨基-4,7-二氢-5H-噻吩并[2,3-c]吡喃-3-甲腈 2-[[(苯甲酰基氨基)硫代甲酰]氨基]-4,7-二氢-5,5-二甲基-5H-噻吩并[2,3-C]吡喃-3-羧酸 (4-甲基-6,7-二氢-4H-噻吩并[3,2-c]吡喃-4-基)乙酸 (2-羧基噻吩-3-基)乙酸酐 2-((8-fluoro-5-methylchroman-6-yl)methyl)-N-methylbenzamide 2,4-(2,5,8,11-tetraoxa)dodecano-3-bromo-5-phenylthiophene 2-(cycloheptanecarbonyl-amino)-4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxylic acid 2-(Cyclopentanecarbonyl-amino)-4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxylic acid ethyl ester 2-[(hexahydro-2,5-methanopentalen-3a(1H)-ylcarbonyl)amino]-N-[(3R)-tetrahydrofuran-3-yl]-4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxamide N-[5-(4-cyanophenyl)methyl-2-thiazolyl]-4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxamide 6,7-dihydro-N-methyl-4H-Thieno[3,2-c]pyran-4-methanamine hydrochloride 5-Methyl-7-oxo-4,5-dihydro-7H-thieno<2.3-c>pyran 5,7-dihydro-7-(4-nitrophenyl)-4H-thieno[2,3-c]pyran 1,9-Dimethyl-4,6-dihydrodithieno<3,4-c:3',4'-e>oxepin-4-on N-(3-cyano-5,7-dihydro-4H-thieno[2,3-c]pyran-2-ylcarbamoyl)benzamide {4-methyl-4,6-dihydrothieno[2,3-c]furan-2-yl}hexahydro-2,5-methanopentalene-3a(1H)-carboxylic acid N-benzoyl-N'-(3-cyano-4,7-dihydro-5H-thieno[2,3-c]pyran-2-yl)thiourea 5,7-dihydro-7,7-dimethyl-4H-thieno[2,3-c]pyran 5,7-dihydro-7-pentyl-4H-thieno[2,3-c]pyran 3-(benzo[d]thiazol-2-yl)-5,7-dihydro-4H-thieno[2,3-c]pyran-2-amine (2-ethyl-6,7-dihydro-4H-thieno[3,2-c]pyran-4-yl)methanamine hydrochloride 2-Bromo-5,5-dimethyl-5H-thieno<3,2-b>pyran